Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]

Yin Q, Li J, Xia Y, Zhang R, et al. Drug Design, Development and Therapy. 2015;9:5407–5419. On page 5410, Figure 2 was wrongly labelled as Figure 3. On page 5410, the Notes for Figure 1 should be: + indicates low risk, - indicates high risk, and ? indicates this is unclear.&nb...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Yin Q (Author), Li J (Author), Xia Y (Author), Zhang R (Author), Wang J (Author), Lu W (Author), Zhou Y (Author), Zheng Y (Author), Abudumijiti H (Author), Chen R (Author), Chen K (Author), Li S (Author), Liu T (Author), Wang F (Author), Lu J (Author), Guo C (Author)
Hōputu: Pukapuka
I whakaputaina: Dove Medical Press, 2015-11-01T00:00:00Z.
Ngā marau:
Urunga tuihono:Connect to this object online.
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
Whakaahuatanga
Whakarāpopototanga:Yin Q, Li J, Xia Y, Zhang R, et al. Drug Design, Development and Therapy. 2015;9:5407–5419. On page 5410, Figure 2 was wrongly labelled as Figure 3. On page 5410, the Notes for Figure 1 should be: + indicates low risk, - indicates high risk, and ? indicates this is unclear.    View original article by Yin et al.
Whakaahutanga tūemi:1177-8881